Evofem Biosciences Stock Total Debt
Evofem Biosciences fundamentals help investors to digest information that contributes to Evofem Biosciences' financial success or failures. It also enables traders to predict the movement of Evofem OTC Stock. The fundamental analysis module provides a way to measure Evofem Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evofem Biosciences otc stock.
Evofem |
Evofem Biosciences OTC Stock Total Debt Analysis
Evofem Biosciences' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Evofem Biosciences Total Debt | 125.74 M |
Most of Evofem Biosciences' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evofem Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Evofem Biosciences has a Total Debt of 125.74 M. This is 95.43% lower than that of the Pharmaceuticals sector and 61.29% lower than that of the Health Care industry. The total debt for all United States stocks is 97.64% higher than that of the company.
Evofem Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evofem Biosciences' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Evofem Biosciences could also be used in its relative valuation, which is a method of valuing Evofem Biosciences by comparing valuation metrics of similar companies.Evofem Biosciences is currently under evaluation in total debt category among its peers.
Evofem Fundamentals
Return On Equity | -3.87 | ||||
Return On Asset | -1.25 | ||||
Operating Margin | (5.41) % | ||||
Current Valuation | 112.69 M | ||||
Shares Outstanding | 121.22 M | ||||
Shares Owned By Insiders | 0.28 % | ||||
Shares Owned By Institutions | 0.57 % | ||||
Number Of Shares Shorted | 8.68 M | ||||
Price To Earning | (1.26) X | ||||
Price To Book | 8.37 X | ||||
Price To Sales | 0.42 X | ||||
Revenue | 8.24 M | ||||
Gross Profit | 4.19 M | ||||
EBITDA | (204.14 M) | ||||
Net Income | (205.19 M) | ||||
Cash And Equivalents | 19.89 M | ||||
Cash Per Share | 0.23 X | ||||
Total Debt | 125.74 M | ||||
Debt To Equity | 8.72 % | ||||
Current Ratio | 0.16 X | ||||
Book Value Per Share | (0.77) X | ||||
Cash Flow From Operations | (146.67 M) | ||||
Short Ratio | 0.19 X | ||||
Earnings Per Share | (19.01) X | ||||
Target Price | 2.9 | ||||
Number Of Employees | 119 | ||||
Beta | -1.25 | ||||
Market Capitalization | 6.41 M | ||||
Total Asset | 42.51 M | ||||
Retained Earnings | (526.68 M) | ||||
Working Capital | 3.78 M | ||||
Current Asset | 16.39 M | ||||
Current Liabilities | 12.61 M | ||||
Z Score | -30.0 | ||||
Net Asset | 42.51 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census. Note that the Evofem Biosciences information on this page should be used as a complementary analysis to other Evofem Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Evofem OTC Stock
If you are still planning to invest in Evofem Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evofem Biosciences' history and understand the potential risks before investing.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |